Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
NPJ Precision Oncology
|
December 5, 2017
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
Ovidiu C Andronesi, Morteza Esmaeili, Ronald J H Borra, et al.
Neuro-Oncology
|
July 6, 2013
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, et al.
Breast Cancer Research and Treatment
|
November 8, 2013
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases
Nancy U Lin, Rachel A Freedman, Naren Ramakrishna, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 17, 2012
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
David P Kodack, Euiheon Chung, Hiroshi Yamashita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2010
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer
Angelo E Volandes, Michael K Paasche-Orlow, Susan L Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Nature Communications
|
March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas
Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Neuro-Oncology
|
June 4, 2011
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
Andrew B Lassman, Fabio M Iwamoto, Timothy F Cloughesy, et al.
Neuro-Oncology
|
June 5, 2012
Initial treatment patterns over time for anaplastic oligodendroglial tumors
Katherine S Panageas, Fabio M Iwamoto, Timothy F Cloughesy, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
NPJ Precision Oncology
|
December 5, 2017
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival
Ovidiu C Andronesi, Morteza Esmaeili, Ronald J H Borra, et al.
Neuro-Oncology
|
July 6, 2013
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, et al.
Breast Cancer Research and Treatment
|
November 8, 2013
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases
Nancy U Lin, Rachel A Freedman, Naren Ramakrishna, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 17, 2012
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
David P Kodack, Euiheon Chung, Hiroshi Yamashita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2010
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer
Angelo E Volandes, Michael K Paasche-Orlow, Susan L Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Nature Communications
|
March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas
Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Neuro-Oncology
|
June 4, 2011
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
Andrew B Lassman, Fabio M Iwamoto, Timothy F Cloughesy, et al.
Neuro-Oncology
|
June 5, 2012
Initial treatment patterns over time for anaplastic oligodendroglial tumors
Katherine S Panageas, Fabio M Iwamoto, Timothy F Cloughesy, et al.
Page
of 7